Promoter holding
64.27%
ND
Neuberg Diagnostics Private Limited - Due diligence report
A 360° intelligence report on Neuberg Diagnostics: trust score, financial health, credit view, compliance, directors, growth and distress si…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹349
50% off
New user
Or enjoy up to 50% off with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Neuberg Diagnostics — 360° Intelligence Report
Generated from MCA filings & public records70/100
Trust Score
Moderate
Neuberg Diagnostics is assessed as Moderate with a Trust Score of 70/100. Neuberg Diagnostics is an active private limited indian non-government company incorporated in 2017, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.
Report generated on 09 Jul 2026 from the latest processed filings. Neuberg Diagnostics Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
70/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
33/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Consolidated · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
- Liabilities ≈ 38% EBITDA - stretched.
- Open charges exceed net worth - secured lenders rank ahead.
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 23 open (1,806.30 cr) · 2 satisfied (1.02 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Others | 9 | 48.0 cr |
| Standard Chartered Bank | 3 | 48.0 cr |
| Hdfc Bank Limited | 13 | 48.0 cr |
Compliance Score: 33/100 Caution Indicated
- Company status is Active as per MCA.
- Balance sheet slightly behind (Mar 2024).
- Flagged by authority: EPFO.
- Litigation present in 1 court forum(s).
- 1 auditor resignation(s) filed - latest: R.SUBRAMANIAN & COMPANY LLP on 2022-03-24.
- Delayed payments to MSME suppliers disclosed (1689 disclosure(s)).
- 12 active GST registration(s).
Legal cases on record (1)
05
Director Intelligence
Stability score: 85/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| ATHMANATHAN GANESAN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SANDIP CHANDRAKANT SHAH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SUJAY RAMAPRASAD | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| GOMATHY BABU SADACHARAM KULANDAIVELU | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RAHUL DILIP SHAH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Vivek Srinivasan | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Roshini Selvakumar | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 7 directors on the board.
- No disqualified or deactivated DINs.
- 2 director exit(s) in the last 3 years.
Director & KMP remuneration (FY 2024)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2024 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
6
Group entities
8
Capital events
3 allotment(s) · 0 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Ncgm Inc. | Subsidiary Company | 74.00% |
| Neuberg Americas Inc. | Subsidiary Company | 74.00% |
| Neuberg Diagnostics Mauritius Private Limited | Subsidiary Company | 74.00% |
| Neuberg A. G Diagnostics Private Limited | Subsidiary Company | 74.00% |
| Minerva Diagnostic Laboratory | Subsidiary Company | 74.00% |
| Neuberg Center For Genomic Medicine Private Limited | Subsidiary Company | 74.00% |
| Neuberg Bose Laboratories Private Limited | Subsidiary Company | 74.00% |
| Neuberg Anand Reference Laboratory Private Limited | Subsidiary Company | 74.00% |
| Neuberg Sai Sridevi Diagnostics Private Limited | Subsidiary Company | 74.00% |
| Neuberg Supratech Rajkot Private Limited | Subsidiary Company | 74.00% |
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 95 · Distress 80
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Profit expanded 2.1x year-on-year.
Asset base grew 24% - capacity expansion.
Net margin improved to 0.86.
EPFO headcount growing - hiring signal.
Operating for 9 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 61% in a year.
Compliance score is weak (33/100).
23 open charge(s) registered - assets are encumbered.
1 auditor resignation(s) on record - review the stated reasons.
MSME payment delays disclosed - latest outstanding 13.97 cr.
1 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence58/100
Review suggested
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment56/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 23 open charge(s) of 1,806.30 cr already registered.
- Compliance gaps should be priced into terms.
Investor view87/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 5 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events19 Dec 2025
Charge created
Standard Chartered Bank - 5.00 Lakh
06 Dec 2025
Charge satisfied
Hdfc Bank Limited
28 Nov 2025
Director appointed
Roshini Selvakumar (Company Secretary)
24 Nov 2025
Charge created
Others - 150.00 cr
22 Jul 2025
Charge created
Others - 15.00 cr
Charge created
Others - 175.00 cr
03 Jun 2025
Charge created
Hdfc Bank Limited - 2.25 cr
29 Mar 2025
Charge created
Hdfc Bank Limited - 2.50 cr
25 Feb 2025
Charge satisfied
Hdfc Bank Limited
10 Jan 2025
Director appointed
RAHUL DILIP SHAH (Nominee Director)
27 Dec 2024
Director appointed
Vivek Srinivasan (Cfo)
19 Dec 2024
Charge created
Others - 895.00 cr
30 Sep 2024
Last AGM held
Annual general meeting
02 Aug 2024
Charge created
Hdfc Bank Limited - 6.40 cr
31 Mar 2024
Latest balance sheet
Filed with ROC
10
Key Observations
Auto-generated from the data aboveRevenue grew 38% over the last 4 financial year(s).
Net profit margin moved from 1.42 to 2.1x.
Debt-to-equity stands at 24% - leverage worth monitoring.
Net worth is positive.
7 active director(s) / partner(s); board looks stable and experienced.
12 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 6 subsidiary(ies) - assess on a consolidated basis.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2024 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 3 security allotment(s) - amounts available in the full report.
1 overseas direct investment(s) (ODI) on record - international footprint.
| Company | CIN | Location |
|---|---|---|
| Looks Health Services | L93030MH2011PLC222636 | Mumbai, Maharashtra, India |
| Medinovaindia | L85110TG1993PLC015481 | Hyderabad, Telangana, India |
| Aspira | L85100MH1973PLC289209 | Mumbai, Maharashtra, India |
| P H Diagnostic Centre Private Limited | U85110PN1995PTC213675 | Pune City, Maharashtra, India |
| Vijaya Diagnostic Centre | L85195TG2002PLC039075 | Hyderabad, Telangana, India |
| Thyrocare | L85110MH2000PLC123882 | Navi Mumbai, Maharashtra, India |
| Medplus | L85110TG2006PLC051845 | Hyderabad, Telangana, India |
| Metropolis India | L73100MH2000PLC192798 | Mumbai, Maharashtra, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Neuberg Diagnostics before audits and certifications: compliance score 33/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Neuberg Diagnostics: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Neuberg Diagnostics - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 70/100, distress signals and MSME payment-delay disclosures - know whether Neuberg Diagnostics pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Neuberg Diagnostics - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Neuberg Diagnostics an active company?
Neuberg Diagnostics has MCA status “Active” with a compliance score of 33/100 (Caution Indicated).
Is Neuberg Diagnostics financially healthy?
Neuberg Diagnostics has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.
Should I do business with Neuberg Diagnostics?
Its overall Trust Score is 70/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Neuberg Diagnostics?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 7 active director(s) are on record.
Does Neuberg Diagnostics have loans or charges against its assets?
23 open charge(s) are registered against its assets, and 2 earlier charge(s) stand satisfied.
Is Neuberg Diagnostics up to date with its ROC filings?
Balance sheet slightly behind (Mar 2024). Overall compliance score: 33/100 (Caution Indicated).
Is it risky to lend to Neuberg Diagnostics?
Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
